₹
90.73
Oct 18
Business Description
Zenotech Laboratories Ltd
ISIN : INE486F01012
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.85 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 19.24 | |||||
Beneish M-Score | -2.47 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 23.8 | |||||
3-Year EBITDA Growth Rate | 39 | |||||
3-Year FCF Growth Rate | 109.1 | |||||
3-Year Book Growth Rate | 23.2 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 56.56 | |||||
9-Day RSI | 54.17 | |||||
14-Day RSI | 55.01 | |||||
6-1 Month Momentum % | 45.15 | |||||
12-1 Month Momentum % | 39.24 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.93 | |||||
Quick Ratio | 1.87 | |||||
Cash Ratio | 1.46 | |||||
Days Inventory | 71.72 | |||||
Days Sales Outstanding | 36.02 | |||||
Days Payable | 219.32 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 88.57 | |||||
Operating Margin % | 15.89 | |||||
Net Margin % | 21.76 | |||||
FCF Margin % | 20.28 | |||||
ROE % | 9.42 | |||||
ROA % | 7.86 | |||||
ROIC % | 4.71 | |||||
ROC (Joel Greenblatt) % | 16.15 | |||||
ROCE % | 12.56 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 70.16 | |||||
PE Ratio without NRI | 69.95 | |||||
Price-to-Owner-Earnings | 171.58 | |||||
PEG Ratio | 1.26 | |||||
PS Ratio | 15.27 | |||||
PB Ratio | 6.29 | |||||
Price-to-Tangible-Book | 6.11 | |||||
Price-to-Free-Cash-Flow | 75.06 | |||||
Price-to-Operating-Cash-Flow | 48.19 | |||||
EV-to-EBIT | 48.02 | |||||
EV-to-EBITDA | 29.45 | |||||
EV-to-Revenue | 14.27 | |||||
EV-to-FCF | 68.88 | |||||
Price-to-Projected-FCF | 25.63 | |||||
Price-to-Median-PS-Value | 1.11 | |||||
Price-to-Peter-Lynch-Fair-Value | 3.48 | |||||
Price-to-Graham-Number | 4.25 | |||||
Price-to-Net-Current-Asset-Value | 52.75 | |||||
Price-to-Net-Cash | 137.47 | |||||
Earnings Yield (Greenblatt) % | 2.09 | |||||
FCF Yield % | 1.37 | |||||
Forward Rate of Return (Yacktman) % | 19.88 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Zenotech Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 374.185 | ||
EPS (TTM) (₹) | 1.33 | ||
Beta | 0.44 | ||
Volatility % | 48.8 | ||
14-Day RSI | 55.01 | ||
14-Day ATR (₹) | 5.27861 | ||
20-Day SMA (₹) | 90.5805 | ||
12-1 Month Momentum % | 39.24 | ||
52-Week Range (₹) | 52.23 - 107.79 | ||
Shares Outstanding (Mil) | 61.03 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Zenotech Laboratories Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Zenotech Laboratories Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Zenotech Laboratories Ltd Frequently Asked Questions
What is Zenotech Laboratories Ltd(BOM:532039)'s stock price today?
When is next earnings date of Zenotech Laboratories Ltd(BOM:532039)?
Does Zenotech Laboratories Ltd(BOM:532039) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |